- Home
- THRD vs BWMX Comparison
THRD vs BWMX Comparison
Compare THRD & BWMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THRD
- BWMX
- Stock Information
- Founded
- THRD 2019
- BWMX 1995
- Country
- THRD United States
- BWMX Mexico
- Employees
- THRD N/A
- BWMX N/A
- Industry
- THRD Biotechnology: Pharmaceutical Preparations
- BWMX Catalog/Specialty Distribution
- Sector
- THRD Health Care
- BWMX Consumer Discretionary
- Exchange
- THRD Nasdaq
- BWMX Nasdaq
- Market Cap
- THRD 513.2M
- BWMX 553.8M
- IPO Year
- THRD 2022
- BWMX N/A
- Fundamental
- Price
- THRD $11.45
- BWMX $12.13
- Analyst Decision
- THRD Strong Buy
- BWMX Strong Buy
- Analyst Count
- THRD 3
- BWMX 1
- Target Price
- THRD $20.33
- BWMX $22.50
- AVG Volume (30 Days)
- THRD 218.2K
- BWMX 28.8K
- Earning Date
- THRD 11-07-2024
- BWMX 10-24-2024
- Dividend Yield
- THRD N/A
- BWMX 11.17%
- EPS Growth
- THRD N/A
- BWMX N/A
- EPS
- THRD N/A
- BWMX 1.21
- Revenue
- THRD N/A
- BWMX $700,821,742.00
- Revenue This Year
- THRD N/A
- BWMX $9.30
- Revenue Next Year
- THRD N/A
- BWMX $6.59
- P/E Ratio
- THRD N/A
- BWMX $9.88
- Revenue Growth
- THRD N/A
- BWMX 6.88
- 52 Week Low
- THRD $7.08
- BWMX $11.67
- 52 Week High
- THRD $16.94
- BWMX $21.28
- Technical
- Relative Strength Index (RSI)
- THRD 40.06
- BWMX 42.06
- Support Level
- THRD $10.10
- BWMX $11.67
- Resistance Level
- THRD $12.49
- BWMX $12.81
- Average True Range (ATR)
- THRD 1.30
- BWMX 0.40
- MACD
- THRD -0.32
- BWMX -0.04
- Stochastic Oscillator
- THRD 25.00
- BWMX 29.11
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
About BWMX Betterware de Mexico S.A.P.I. de C.V.
Betterware de Mexico SAPI de CV is a direct-to-consumer selling company. The company operates through two business segments: the home organization products (Betterware segment or BWM segment) and the beauty and personal care products (B and PC) (JAFRA segment). The Betterware's segment is divided into different categories based on the type of products it sells and includes, kitchen and food preservation, home solutions, bathroom, laundry & cleaning, tech and mobility, and bedroom and wellness products. The JAFRA's segment is divided into fragrance, color, skincare, and toiletries products. The company generates a majority of its revenue from the Beauty and personal care (B&PC) (JAFRA segment). Geographically, key revenue for the company is derived from Mexico.